These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 2169077

  • 1. Association between plasma levels of tissue plasminogen activator and postoperative deep vein thrombosis--influence of prophylaxis with a low molecular weight heparin. The Venous Thrombosis Group.
    Sørensen JV, Borris LC, Lassen MR, Christiansen HM, Schøtt P, Olsen AD, Neerstrand HS.
    Thromb Res; 1990 Jul 01; 59(1):131-8. PubMed ID: 2169077
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. External pneumatic compression and fibrinolysis in abdominal surgery.
    Cahan MA, Hanna DJ, Wiley LA, Cox DK, Killewich LA.
    J Vasc Surg; 2000 Sep 01; 32(3):537-43. PubMed ID: 10957661
    [Abstract] [Full Text] [Related]

  • 4. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H.
    Thromb Haemost; 1996 Feb 01; 75(2):246-50. PubMed ID: 8815569
    [Abstract] [Full Text] [Related]

  • 5. Components of coagulation and fibrinolysis during thrombosis prophylaxis with a low molecular weight heparin (Enoxaparin) versus Dextran 70 in hip arthroplasty.
    Borris LC, Sørensen JV, Lassen MR, Walenga JM, Fareed J, Jørgensen LN, Hauch O, Wille-Jørgensen P.
    Thromb Res; 1991 Jul 01; 63(1):21-8. PubMed ID: 1719655
    [Abstract] [Full Text] [Related]

  • 6. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, Lange P, Brish LK, McGee K, Beleski K, Pawlak J, Mammen E, Sajahan NP, Kozol RA.
    J Surg Res; 1998 Jan 01; 74(1):96-101. PubMed ID: 9536981
    [Abstract] [Full Text] [Related]

  • 7. Thrombosis after hip replacement. Relationship to the fibrinolytic system.
    Eriksson BI, Eriksson E, Gyzander E, Teger-Nilsson AC, Risberg B.
    Acta Orthop Scand; 1989 Apr 01; 60(2):159-63. PubMed ID: 2471386
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.
    Leyvraz PF, Bachmann F, Hoek J, Büller HR, Postel M, Samama M, Vandenbroek MD.
    BMJ; 1991 Sep 07; 303(6802):543-8. PubMed ID: 1655136
    [Abstract] [Full Text] [Related]

  • 11. Low-molecular-weight heparin (enoxaparin) vs dextran 70. The prevention of postoperative deep vein thrombosis after total hip replacement. The Danish Enoxaparin Study Group.
    Arch Intern Med; 1991 Aug 07; 151(8):1621-4. PubMed ID: 1714709
    [Abstract] [Full Text] [Related]

  • 12. Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery.
    Dahl OE, Aspelin T, Arnesen H, Seljeflot I, Kierulf P, Ruyter R, Lyberg T.
    Thromb Res; 1995 Nov 15; 80(4):299-306. PubMed ID: 8585042
    [Abstract] [Full Text] [Related]

  • 13. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).
    Marassi A, Balzano G, Mari G, D'Angelo SV, Della Valle P, Di Carlo V, D'Angelo A.
    Int Surg; 1993 Nov 15; 78(2):166-70. PubMed ID: 8394842
    [Abstract] [Full Text] [Related]

  • 14. Reduction of plasma levels of prothrombin fragments 1 and 2 during thromboprophylaxis with a low-molecular-weight heparin.
    Sørensen JV, Lassen MR, Borris LC, Rahr HB, Jensen HP, Hoppensteadt D, Walenga JA, Fareed J.
    Blood Coagul Fibrinolysis; 1992 Feb 15; 3(1):55-9. PubMed ID: 1320416
    [Abstract] [Full Text] [Related]

  • 15. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
    Br J Surg; 1988 Nov 15; 75(11):1058-63. PubMed ID: 2905187
    [Abstract] [Full Text] [Related]

  • 16. Levels of thrombin--antithrombin-III complex and factor VIII activity in relation to post-operative deep vein thrombosis and influence of prophylaxis with a low-molecular-weight heparin.
    Sørensen JV, Borris LC, Lassen MR, Christiansen HM, Schøtt P, Olsen AD.
    Blood Coagul Fibrinolysis; 1990 Oct 15; 1(4-5):389-92. PubMed ID: 1966794
    [Abstract] [Full Text] [Related]

  • 17. Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis.
    Kakkar VV, Stringer MD, Hedges AR, Parker CJ, Welzel D, Ward VP, Sanderson RM, Cooper D, Kakkar S.
    Am J Surg; 1989 Apr 15; 157(4):413-8. PubMed ID: 2539025
    [Abstract] [Full Text] [Related]

  • 18. Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients.
    Eriksson BI, Eriksson E, Risberg B.
    Thromb Res; 1991 Apr 15; 62(1-2):55-64. PubMed ID: 1853306
    [Abstract] [Full Text] [Related]

  • 19. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
    Trotti R, Siragusa S, Rondanelli M, Chezzi L, Citterio A, Melzi d'Eril GV, Piovella F.
    Haematologica; 1997 Apr 15; 82(2):178-81. PubMed ID: 9175322
    [Abstract] [Full Text] [Related]

  • 20. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V, Bachmann F, Hauert J, Christe MA, Kruithof EK.
    Thromb Haemost; 1992 Apr 02; 67(4):397-401. PubMed ID: 1631786
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.